rs180177207
Variant summary
Our verdict is Pathogenic. The variant received 17 ACMG points: 17P and 0B. PM1PM2PM5PP2PP3_ModeratePP5_Very_Strong
The NM_000030.3(AGXT):c.346G>A(p.Gly116Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000939 in 1,597,378 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G116W) has been classified as Pathogenic.
Frequency
Consequence
NM_000030.3 missense
Scores
Clinical Significance
Conservation
Publications
- alanine glyoxylate aminotransferase deficiencyInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- primary hyperoxaluria type 1Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Myriad Women’s Health, Ambry Genetics, Labcorp Genetics (formerly Invitae), Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 17 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152214Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.00000426 AC: 1AN: 234802 AF XY: 0.00000793 show subpopulations
GnomAD4 exome AF: 0.00000830 AC: 12AN: 1445164Hom.: 0 Cov.: 34 AF XY: 0.0000112 AC XY: 8AN XY: 716822 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152214Hom.: 0 Cov.: 33 AF XY: 0.0000134 AC XY: 1AN XY: 74360 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Primary hyperoxaluria, type I Pathogenic:6
- -
- -
This submission and the accompanying classification are no longer maintained by the submitter. For more information on current observations and classification, please contact variantquestions@myriad.com. -
- -
- -
- -
not provided Pathogenic:1
This sequence change replaces glycine, which is neutral and non-polar, with arginine, which is basic and polar, at codon 116 of the AGXT protein (p.Gly116Arg). This variant is present in population databases (rs180177207, gnomAD 0.003%). This missense change has been observed in individual(s) with primary hyperoxaluria (PMID: 10453743, 17460142, 25629080, 26252291, 33691640). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 189021). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on AGXT protein function. For these reasons, this variant has been classified as Pathogenic. -
Abnormality of metabolism/homeostasis Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at